A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

E. J. Rhee, W. Y. Lee, K. H. Yoon, S. J. Yoo, I. K. Lee, S. H. Baik, Y. K. Kim, M. K. Lee, K. S. Park, J. Y. Park, B. S. Cha, H. W. Lee, K. W. Min, H. Y. Bae, M. J. Kim, J. A. Kim, D. K. Kim, Sun Woo Kim

    Research output: Contribution to journalArticlepeer-review

    34 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes'. Together they form a unique fingerprint.

    Medicine & Life Sciences